期刊文献+

正常核型和异常核型骨髓增生异常综合征的细胞形态学特点比较 被引量:3

A comparative study on morphological features between myelodysplastic syndrome with normal karyotype and abnormal karyotype
下载PDF
导出
摘要 目的:比较正常核型和异常核型骨髓增生异常综合征(MDS)的细胞形态学的特点。方法:回顾分析82例MDS患者,通过对正常核型和异常核型MDS患者的细胞形态进行观察,分析二者形态学的差别。结果:核型异常组31例,占37.8%,核型正常组51例,占62.2%,2组外周血比较,核型异常组易出现原粒细胞、早幼红细胞、大红细胞,P<0.05;骨髓细胞形态比较,核型异常组三系病态造血比例高(>30%),P<0.05;原粒、淋巴样小巨核和畸形血小板比例高,P<0.05;核型异常组红系病态造血易见子母核、奇数核和多核,P<0.05;核型异常组有6例转为急性白血病。结论:异常核型MDS较正常核型组细胞病态造血发生率明显增高,原始细胞比例增高,转为白血病的比例高,预后差。 Objective:To evaluate morphological features of myelodysplastic syndrome(MDS) with normal karyotype or abnormal karyotype.Method:Eighty-two MDS patients were analyzed retrospectively.The morphological features of patients with normal karyotype were compared with those of patients with abnormal karyotype Result:Thirty-one cases(37.8%) were with abnormal karyotype and fifty-one cases(62.2%) were with normal karyotype.In abnormal karyotype group,myeloblast,macroerythrocyte and prorubricyte more easily presented in peripheral blood(P0.05).Rates of three lineages dysplasia(30%),myeloblasts,lymphoid micromegakaryocytes and abnormal platelets were higher in abnormal karyotype group than those in control group(P0.05).Erythroid multi-nuclei,odd nucleus and mother-child nucleus were observed in abnormal karyotype group.Six patients in abnormal karyotype group transformed to acute myelogenous leukaemia(AML).Conclusion:MDS with abnormal karyotype is with higher incidence of dysplasia,ratio of blast cells and risk of transformation to AML.
出处 《临床血液学杂志》 CAS 2011年第2期165-167,共3页 Journal of Clinical Hematology
关键词 骨髓增生异常综合征 核型分析 外周血 骨髓 细胞形态 myelodysplastic syndrome karyotype peripheral blood bone marrow morphology
  • 相关文献

参考文献12

二级参考文献32

  • 1陈苏宁,薛永权,吴亚芳,潘金兰.一例伴有t(6;11)(q27;q23)的急性单核细胞白血病患者的遗传学研究[J].中华血液学杂志,2004,25(8):494-495. 被引量:7
  • 2施均,邵宗鸿,刘鸿,贾海蓉,孙娟,白洁,吴玉红,井丽萍,何广胜,曹燕然,王秀丽,梅峰,郝玉书,杨天楹.骨髓增生异常综合征患者骨髓细胞周期及CD34^+细胞增殖特征的研究[J].中华血液学杂志,2004,25(11):641-644. 被引量:10
  • 3Vardiman JW, Harris NL, Brunning RD. The World Health Organization( WHO ) classification of the myeloid neoplasms. Blood, 2002,100:2292-2302.
  • 4Shaffer LG, Tommerap N. ISCN 2005: an international system for human cytogenetic nomenclature. Basel: Karger, 2004.
  • 5Jaffe ES, Harris NL, Stein H, et al. World Health Organization classfication of tumours of haematopoietic and lymphoid tissues. Lyon : IARC Press, 2001:61-73 .
  • 6Chert Z, Morgan R, Stone JF, et al. Fish: a useful technique in the verification of clonality of random chromosome abnormalities. Cancer Genat Cytogenet, 1993,66:73-74.
  • 7van Lom K, Houtsmuller AB, van Putten WL, et al. Cytogenetie clonality analysis of megakaryocytes in myelodysplastic syndrome by dual-color fluorescence in situ hybridization and confocal laser scanning microscopy. Genes Chromosomes Cancer, 1999,25:332- 338.
  • 8Bigoni R, Cuneo A, Milani R, et al. Multilineage involvement in the 5q - syndrome: a fluorescent in situ hybridization study on bone marrow smears. Haematologica, 2001, 86:375-381.
  • 9Godon C, Talmant P, Garand R, et al. Deletion of 5q31 is observed in megakaryocytic cells in patients with myelodysplastie syndromes and adel (5q) , including the 5q - syndrome. Genes Chromosomes Cancer, 2000, 29:350-352.
  • 10Hast R, Eriksson M, Widell S, et al. Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes. Leuk Res, 1999,23: 579-584.

共引文献31

同被引文献28

  • 1陆再英,等.内科学.第七版.北京:人民卫生出版社,2008:494-496.
  • 2Tefferi A,Vardiman JW.Myelodysplastic syndromes.N Engl J Med,2009; 361(19):1872-85.
  • 3Brunning RD,Orazi A,Germing U,et al.Myelodysplastic syndrome/neoplasms,overview.In:IARC.WHO classification of tumours of haematopoietic and lymphoid tissues.Lyon:IARC,2008:88-93.
  • 4M itelman F.ISCN:guidelines for cancer cytogenetics,supplement to an intemational system for human cgtogenet icnom enclature.Switzerland:Karger Publishers,1995:144-148.
  • 5Coleman JF,Theil KS,Tubbs RR,et al.Diagnostic Yield of Bone Marrow and Peripheral Blood FISH Panel Testing in Clinically Suspected Myelodysplastic Syndromes and/or Acute Myeloid Leukemia A Prospective Analysis of 433 Cases.American journal of clinical pathology,2011 ; 135(6):915-920.
  • 6Jiang H,Xue Y,Wang Q,et al.The utility of fluorescence in situ hybridization analysis in diagnosing myelodysplastic syndromes is limited to cases with karyotype failure.Leukemia research,2012; 36(4):448-452.
  • 7Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues [ M ]. Lyon, France : IARC ,2008.
  • 8Tomonaga M. Nuclear abnormaliiies in Pelger-Huet anomaly : pro- gress in blood cell morphology[ J]. Rinsho Byori,2005,53 (1) : 54-60.
  • 9Rong W,Cary PG,Kevin F,et al.The impact of hypomethylating agents on the cost of care and survival of elderly patients with myelodysplastic syndromes[J].Leukemia Research,2012,36(11):1370-1375.
  • 10James MF,Jamile MS.Clinical presentation,diagnosis,and prognosis of myelodysplastic syndromes[J].Am J Med,2012,125(7 Suppl):S6-S13.

引证文献3

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部